Pasireotide pamoate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for pasireotide pamoate and what is the scope of freedom to operate?
Pasireotide pamoate
is the generic ingredient in one branded drug marketed by Recordati Rare and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Pasireotide pamoate has one hundred and thirty-five patent family members in fifty-three countries.
One supplier is listed for this compound.
Summary for pasireotide pamoate
International Patents: | 135 |
US Patents: | 3 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 11 |
Patent Applications: | 15 |
DailyMed Link: | pasireotide pamoate at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for pasireotide pamoate
Generic Entry Date for pasireotide pamoate*:
Constraining patent/regulatory exclusivity:
Dosage:
FOR SUSPENSION;INTRAMUSCULAR |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for pasireotide pamoate
Expired US Patents for pasireotide pamoate
International Patents for pasireotide pamoate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Peru | 20050581 | MICROPARTICULAS QUE COMPRENDEN ANALOGOS DE SOMATOSTATINA | ⤷ Try a Trial |
Colombia | 6241097 | UNA COMPOSICION DE LIBERACION PROLONGADA QUE COMPRENDE UN DERIVADO DE SOMATOSTATINA EN MICROPARTICULAS | ⤷ Try a Trial |
Russian Federation | 2404749 | МИКРОЧАСТИЦЫ, СОДЕРЖАЩИЕ АНАЛОГИ СОМАТОСТАТИНА (MICROPARTICLES CONTAINING ANALOGS OF SOMATOSTATIN) | ⤷ Try a Trial |
European Patent Office | 2164473 | UNE COMPOSITION À LIBÉRATION CONTROLÉE QUI CONTIENT UNE DÉRIVÉ DE SOMATOSTATINE DANS LES MICROPARTICULES (AN EXTENDED-RELEASE COMPOSITION COMPRISING A SOMATOSTATIN DERIVATIVE IN MICROPARTICLES) | ⤷ Try a Trial |
Australia | 2008252931 | An extended-release composition comprising a somatostatin derivative in microparticles | ⤷ Try a Trial |
Norway | 331093 | ⤷ Try a Trial | |
Morocco | 28155 | COMPOSITION PHARMACEUTIQUE | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for pasireotide pamoate
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1686964 | C300716 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: PASIREOTIDE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN OF EEN HYDRAAT DAARVAN; REGISTRATION NO/DATE: EU/1/12/753 20141119 |
1307486 | CR 2012 00024 | Denmark | ⤷ Try a Trial | PRODUCT NAME: PASIREOTID OG FARMACEUTISK ACCEPTABLE SALTE DERAF, HERUNDER PASIREOTIDDIASPARTAT; REG. NO/DATE: EU/1/12/753/001-012 20120424 |
1686964 | 122015000015 | Germany | ⤷ Try a Trial | PRODUCT NAME: PASIREOTID ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON ODER JEGLICHES HYDRAT DAVON; REGISTRATION NO/DATE: EU/1/12/753/013-017 20141119 |
1307486 | C01307486/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: PASIREOTID; REGISTRATION NO/DATE: SWISSMEDIC 61254 02.11.2012 |
1686964 | PA2015009 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: PASIREOTIDUM; REGISTRATION NO/DATE: EU/1/12/753/13 - EU/1/12/753/17 20141119 |
1307486 | 132012902062571 | Italy | ⤷ Try a Trial | PRODUCT NAME: PASIREOTIDE DIASPARTATO(SIGNIFOR); AUTHORISATION NUMBER(S) AND DATE(S): EU71/12/753/001-012, 20120424 |
1307486 | 12C0041 | France | ⤷ Try a Trial | PRODUCT NAME: CYCLO((4R)-4(2-AMINOETHYLCARBAMOYLOXY)-L-PROLYL-L-PHENYLGLYCYL-D-TRYPTOPHYL-L-LYSYL-4-O-BENZYL-L-TYROSYL-L-PHENYLALANYL-) : PASIREOTIDE, OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/12/753/001 20120424 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |